Silvio Ken Garattini

1.4k total citations
42 papers, 733 citations indexed

About

Silvio Ken Garattini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Silvio Ken Garattini has authored 42 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Silvio Ken Garattini's work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Silvio Ken Garattini is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Silvio Ken Garattini collaborates with scholars based in Italy, United States and Switzerland. Silvio Ken Garattini's co-authors include L. Valzelli, Antonio Giachetti, L. Pieri, A. Jori, Debora Basile, Enrico Garattini, Gabriela Paroni, Adriana Zanetti, Marco Bolis and Maurizio Gianni’ and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Silvio Ken Garattini

35 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvio Ken Garattini Italy	13	279	278	180	78	77	42	733
Tsion Z. Minas United States	16	200 0.7×	310 1.1×	128 0.7×	125 1.6×	58 0.8×	27	645
Simon B. Zeichner United States	14	375 1.3×	175 0.6×	171 0.9×	169 2.2×	47 0.6×	34	710
Maria Alice Franzoi France	16	568 2.0×	155 0.6×	332 1.8×	167 2.1×	62 0.8×	51	868
Patrizia Serra Italy	19	593 2.1×	277 1.0×	261 1.4×	244 3.1×	57 0.7×	51	1.0k
Jae Kim South Korea	14	151 0.5×	232 0.8×	96 0.5×	51 0.7×	35 0.5×	24	648
Monika Lamba Saini India	12	261 0.9×	269 1.0×	119 0.7×	69 0.9×	40 0.5×	32	668
Derek Cox United States	7	202 0.7×	141 0.5×	110 0.6×	155 2.0×	26 0.3×	13	544
Rachel W. Miller United States	15	238 0.9×	208 0.7×	112 0.6×	237 3.0×	59 0.8×	54	959
Andrew Walding United Kingdom	15	567 2.0×	250 0.9×	673 3.7×	110 1.4×	133 1.7×	32	1.1k
Laurence Goethals Belgium	16	237 0.8×	176 0.6×	247 1.4×	191 2.4×	25 0.3×	25	832

Countries citing papers authored by Silvio Ken Garattini

Since Specialization

Citations

This map shows the geographic impact of Silvio Ken Garattini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio Ken Garattini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio Ken Garattini more than expected).

Fields of papers citing papers by Silvio Ken Garattini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvio Ken Garattini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio Ken Garattini. The network helps show where Silvio Ken Garattini may publish in the future.

Co-authorship network of co-authors of Silvio Ken Garattini

This figure shows the co-authorship network connecting the top 25 collaborators of Silvio Ken Garattini. A scholar is included among the top collaborators of Silvio Ken Garattini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvio Ken Garattini. Silvio Ken Garattini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pietrantonio, Filippo, Giovanni Randon, Sara Lonardi, et al.. (2024). Ramucirumab plus paclitaxel as switch maintenance versus continuation of oxaliplatin-based chemotherapy in patients (pts) with advanced HER2-negative gastric or gastroesophageal junction (GEJ) cancer: The ARMANI phase III trial.. Journal of Clinical Oncology. 42(17_suppl). LBA4002–LBA4002. 3 indexed citations

Garattini, Silvio Ken, Debora Basile, Vallì De Re, et al.. (2024). The potential of retinoic acid receptors as prognostic biomarkers and therapeutic targets in gastric cancer. Frontiers in Oncology. 14. 1453934–1453934.

Raimondi, A., Sara Lonardi, Sabina Murgioni, et al.. (2024). 423P Multicentre, multi-cohort, single-arm phase II trial of tremelimumab and durvalumab as neoadjuvant or definitive treatment of patients (pts) with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC): The INFINITY study. Annals of Oncology. 35. S172–S172. 1 indexed citations

Pascuzzo, Riccardo, Silvio Ken Garattini, & Fabio Martino Doniselli. (2024). Clinical Application of Radiomics in Oncology: Where Do We Stand?. Journal of Magnetic Resonance Imaging. 60(6). 2745–2746. 2 indexed citations

Nardo, Paola Di, Debora Basile, Ana Paula dos Reis Velloso Siciliano, et al.. (2023). Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA). Digestive and Liver Disease. 56(5). 786–794.

Re, Vallì De, Lara Alessandrini, Giulia Brisotto, et al.. (2022). HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma. Cancers. 14(5). 1266–1266. 7 indexed citations

Nardo, Paola Di, Silvio Ken Garattini, V. Fanotto, et al.. (2022). Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review. Cancers. 14(6). 1502–1502. 6 indexed citations

Garattini, Silvio Ken, M. Cinausero, Marianna Macerelli, et al.. (2022). Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice. Current Oncology. 29(10). 6776–6786. 3 indexed citations

Lisanti, C., Debora Basile, Silvio Ken Garattini, et al.. (2022). The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer. Cancers. 15(1). 175–175. 9 indexed citations

10.

Garattini, Silvio Ken, Debora Basile, Marta Bonotto, et al.. (2021). Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer. Cancers. 13(14). 3504–3504. 7 indexed citations

11.

Bolis, Marco, Gabriela Paroni, Maddalena Fratelli, et al.. (2020). All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells. Cancers. 12(5). 1169–1169. 20 indexed citations

12.

Basile, Debora, Lorenzo Gerratana, Angela Buonadonna, et al.. (2019). Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer. Cancers. 11(6). 880–880. 12 indexed citations

13.

Basile, Debora, Paola Di Nardo, Carla Corvaja, et al.. (2019). Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside. Cancers. 11(6). 857–857. 89 indexed citations

14.

Rossini, Daniele, Chiara Cremolini, Marzia Del Re, et al.. (2018). Abstract CT088: Efficacy of anti-EGFR rechallenge in RAS and BRAF wt metastatic colorectal cancer: Clinical and translational results of the phase II CRICKET study by GONO. Cancer Research. 78(13_Supplement). CT088–CT088.

15.

Leone, Francesco, Roberto Filippi, Andrea Palloni, et al.. (2017). Prognostic factors in unresectable biliary tract cancer: a GICO (Gruppo Italiano COlangiocarcinoma) retrospective analysis. Annals of Oncology. 28. vi48–vi48.

16.

Bonotto, Marta, Silvio Ken Garattini, Debora Basile, et al.. (2017). Immunotherapy for gastric cancers: emerging role and future perspectives. Expert Review of Clinical Pharmacology. 10(6). 609–619. 30 indexed citations

17.

Garattini, Silvio Ken, Debora Basile, Monica Cattaneo, et al.. (2017). Molecular classifications of gastric cancers: Novel insights and possible future applications. World Journal of Gastrointestinal Oncology. 9(5). 194–194. 45 indexed citations

18.

Garattini, Enrico, Marco Bolis, Silvio Ken Garattini, et al.. (2014). Retinoids and breast cancer: From basic studies to the clinic and back again. Cancer Treatment Reviews. 40(6). 739–749. 104 indexed citations

19.

Vecchia, Carlo La, Fabio Levi, Franca Lucchini, & Silvio Ken Garattini. (1991). Progress of anticancer drugs in reducing mortality from selected cancers in Europe. Anti-Cancer Drugs. 2(3). 215–222. 33 indexed citations

20.

Bianchi, Roberto, et al.. (1978). The enterohepatic circulation of oxazepam-O-glucuronide in guinea-pigs. Journal of Pharmacy and Pharmacology. 30(1). 185–186. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact